Infographic: Leqembi – A Geographical Comparison

 
• By Anabel Costa-Ferreira

The Pink Sheet explores how regulatory approvals for Leqembi differ around the world, and looks at what is coming next.

Eisai and Biogen's follow-up Alzheimer's treatment has met with varying success around the globe. (Shutterstock/AI-generated)

More from Regional Comparisons

More from Europe